ZL
LMAT icon

Zeke LP’s LeMaitre Vascular LMAT Stock Holding History

Zeke LP’s Portfolio LMAT Stock Details LMAT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2013
Q4 		– Sell
-96,464
Closed -$646K – 57
2013
Q3 		$646K Sell
96,464
-3,536
-4% -$23.9K 0.76% 48
2013
Q2 		$654K Buy
+100,000
New +$630K 0.86% 44

Other funds holding LMAT

Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
GIM
Granahan Investment Management Waltham, Massachusetts $2.07B AUM 56.45% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
CC
Cannell Capital Alta, Wyoming $163M AUM 40.62% 1-Year Est. Return
LAM
Lapides Asset Management Greenwich, Connecticut $153M AUM 9.03% 1-Year Est. Return
AWMDMG
Austin W. Marxe & David M. Greenhouse New York $733M AUM 21.72% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
KCM
Kennedy Capital Management St Louis, Missouri $4.72B AUM 36.69% 1-Year Est. Return
FLAM
First Light Asset Management Edina, Minnesota $1.12B AUM 114.45% 1-Year Est. Return
PCM
Perkins Capital Management Wayzata, Minnesota $107M AUM 82.62% 1-Year Est. Return

Zeke LP's LMAT Position: Q4 2013 in Review

Zeke LP sold out of LeMaitre Vascular (LMAT) in Q4 2013, closing a stake of 96,464 shares — an estimated $646K sold.

Zeke LP first reported a position in LMAT in Q2 2013 and held it in 2 quarters. The position peaked at $654K in Q2 2013. 44 funds tracked by Wall St. Rank hold LMAT as of Q4 2013.

  • Zeke LP reported no remaining LeMaitre Vascular position as of Q4 2013 after selling out during the quarter.
  • Zeke LP sold 96,464 LeMaitre Vascular shares in Q4 2013, an estimated $646K.
  • Zeke LP first reported a position in LeMaitre Vascular in Q2 2013 and held it in 2 quarters.
  • Zeke LP's LeMaitre Vascular position peaked at $654K in Q2 2013.
  • 44 funds tracked by Wall St. Rank held LeMaitre Vascular as of Q4 2013.

Based on Zeke LP's 13F filing for Q4 2013, filed 10 Feb 2014.